IVC FILTER STUDY GROUP FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

JEANNE LABERGE

Phone

7036911805

Tax Period

2022-01-01 to 2022-12-31

IVC FILTER STUDY GROUP FOUNDATION, founded in 2012, is a small nonprofit that reported $223K in total revenue in fiscal year 2022. Revenue fell 79% from the prior year — a significant decline worth monitoring. Expenses of $894K exceeded revenue, resulting in a 301% operating deficit.

Mission

IVC FILTER STUDY GROUP FOUNDATION (IVCF) ADVANCES, ENCOURAGES, & SUPPORTS MEDICAL RESEARCH, SCIENTIFIC STUDIES, & EDUCATION WITH THE GOAL OF IMPROVING PATIENT SAFETY, SURGICAL OUTCOMES, METHODS & PRACTICE WITH A FOCUS ON VASCULAR SURGERY & INTERVENTIONAL RADIOLOGY.

Program Service Accomplishments

Program 1

Expenses: $723,315

IVCF'S INITIAL STUDY, "PRESERVE" IS THE FIRST LARGE-SCALE, MULTISPECIALTY PROSPECTIVE STUDY TO EVALUATE THE USE OF IVC FILTERS AND RELATED FOLLOW-UP TREATMENT.PRESERVE DATA ALLOWS A SYSTEMATIC...

IVCF'S INITIAL STUDY, "PRESERVE" IS THE FIRST LARGE-SCALE, MULTISPECIALTY PROSPECTIVE STUDY TO EVALUATE THE USE OF IVC FILTERS AND RELATED FOLLOW-UP TREATMENT.PRESERVE DATA ALLOWS A SYSTEMATIC, FUNCTIONAL VIEW, REPRESENTATIVE OF ALL FILTERS PLACED IN THE UNITED STATES, THUS, ALL STAKEHOLDERS-INDIVIDUALS, HEALTH CARE PROFESSIONALS, INSURERS AND GOVERNMENT REGULATORS - WILL BE ARMED WITH THE KNOWLEDGE THEY NEED ON PATIENT RISK AND, SUBSEQUENTLY, QUALITY IMPROVEMENT IN FILTER PLACEMENT, MANAGEMENT AND RETRIEVAL. THIS STUDY EVALUATED THE OVERALL SAFETY AND EFFICIENCY OF FILTERS PLACED BY DOCTORS AND ENROLLED 1,420 PATIENTS. IVCF CONCLUDED THE CLINICAL STUDY ACTIVITIES IN THE SECOND QUARTER OF 2022. UPON CONCLUSION OF THE STUDY, IVCF IS PERFORMING OTHER ACTIVITIES SUCH AS ANALYSIS OF THE RESULTS OF THE STUDY AND PUBLICATION OF A PAPER DETAILING THE RESULTS OF THE STUDY. THE STUDY FINDINGS WILL BE DISSEMINATED AS APPROPRIATE TO THE MANUFACTURERS WHO SPONSORED THE STUDY. IVCF IS ALSO EXPECTED TO PROMOTE THE RESULTS OF THE STUDY IN THE NEXT TWO YEARS FOLLOWING THE CONCLUSION OF THE STUDY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $222,948

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $222,948

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $723,315

Other Expenses $894,273

TOTAL EXPENSES $894,273

Year-over-Year Comparison

	2022	2021	Change
Revenue	$222,948	$1,080,532	-0.8%
Expenses	$894,273	$1,384,777	-0.4%
Net Income	$-671,325	$-304,245	+1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JEANNE LABERGE	PRESIDENT	0.50	Officer Director	$0	$0	$0
PETER F LAWRENCE MD	VICE PRESIDENT	0.50	Officer Director	$0	$0	$0
KEITH HUME	TREASURER	0.50	Officer Director	$0	$0	$0
KENNETH M SLAW PHD	SECRETARY	0.80	Officer Director	$0	$0	$0
PETER GLOVICZKI MD FACS	DIRECTOR	0.50	Director	$0	$0	$0
MARSHALL E HICKS MD FSIR	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$222,948	$894,273	$283,336	$-671,325
2021	$1,080,532	$1,384,777	$1,093,025	$-304,245
2020	$1,665,465	$1,511,519	$1,634,942	$153,946
2019	$1,675,074	$1,834,242	$1,440,759	$-159,168
2018	$1,592,033	$2,155,234	$2,039,063	$-563,201